Literature DB >> 22937214

Extrahepatic biliary cancer: New staging classification.

Dhakshinamoorthy Ganeshan1, Fanny E Moron, Janio Szklaruk.   

Abstract

Tumor staging defines the point in the natural history of the malignancy when the diagnosis is made. The most common staging system for cancer is the tumor, node, metastases classification. Staging of cancers provides useful parameters in the determination of the extent of disease and prognosis. Cholangiocarcinoma are rare and refers to cancers that arise from the biliary epithelium. These tumors can occur anywhere along the biliary tree. These tumors have been previously divided into extrahepatic and intrahepatic lesions. Until recently the extrahepatic bile duct tumors have been considered as a single entity per American Joint Commission on Cancer (AJCC) staging classification. The most recent changes to the AJCC classification of bile duct cancers divide the tumors into two major categories: proximal and distal tumors. This practical classification is based on anatomy and surgical management. High quality cross-sectional computed tomography (CT) and/or magnetic resonance (MR) imaging of the abdomen are essential information to accurately stage this tumors. Imaging plays an important role in diagnosis, localization, staging and optimal management of cholangiocarcinoma. For example, it helps to localize the tumor to either perihilar or distal bile duct, both of which have different management. Further, it helps to accurately stage the disease and identify the presence of significant nodal and distant metastasis, which may preclude surgery. Also, it helps to identify the extent of local invasion, which has a major impact on the management. For example, extensive involvement of hepatic duct reaching up to second-order biliary radicals or major vascular encasement of portal vein or hepatic arteries precludes curative surgery and patient may be managed by palliative therapy. Further, imaging helps to identify any anatomical variations in the hepatic arterial or venous circulation and biliary ductal system, which is vital information for surgical planning. This review presents relevant clinical presentation and imaging acquisition and presentation for the accurate staging classification of bile duct tumors based on the new AJCC criteria. This will be performed with the assistance of anatomical diagrams and representative CT and MR images. The image interpretation must include all relevant imaging information for optimum staging. Detailed recommendations on the items required on the radiology report will be presented.

Entities:  

Keywords:  American Joint Commission on Cancer; Bile duct tumors; Computed tomography; Magnetic resonance; Staging

Year:  2012        PMID: 22937214      PMCID: PMC3430732          DOI: 10.4329/wjr.v4.i8.345

Source DB:  PubMed          Journal:  World J Radiol        ISSN: 1949-8470


  22 in total

1.  Staging of pancreatic cancer with multidetector CT in the setting of preoperative chemoradiation therapy.

Authors:  E P Tamm; E M Loyer; S Faria; C P Raut; D B Evans; R A Wolff; C H Crane; R A Dubrow; C Charnsangavej
Journal:  Abdom Imaging       Date:  2006-02-07

Review 2.  Cancers of the pancreas and biliary tract: epidemiological considerations.

Authors:  J F Fraumeni
Journal:  Cancer Res       Date:  1975-11       Impact factor: 12.701

3.  [Surgical treatment of hilus cancers].

Authors:  H Bismuth; D Castaing
Journal:  Acta Chir Belg       Date:  1984 Sep-Oct       Impact factor: 1.090

Review 4.  Surgical aspects in management of hepato-pancreatico-biliary tumours in the elderly.

Authors:  Pierluigi di Sebastiano; Leonardina Festa; Markus W Büchler; Fabio F di Mola
Journal:  Best Pract Res Clin Gastroenterol       Date:  2009       Impact factor: 3.043

5.  Gadoxate-enhanced T 1-weighted MR cholangiography: comparison of 1.5 T and 3.0 T.

Authors:  C Koelblinger; W Schima; M Weber; T Mang; S Nemec; C Kulinna-Cosentini; N Bastati; A Ba-Ssalamah
Journal:  Rofo       Date:  2009-04-07

6.  Surgery for hilar cholangiocarcinoma: the Leeds experience.

Authors:  E Hidalgo; S Asthana; H Nishio; J Wyatt; G J Toogood; K R Prasad; J P A Lodge
Journal:  Eur J Surg Oncol       Date:  2007-11-26       Impact factor: 4.424

Review 7.  Cholangiocarcinoma: current and novel imaging techniques.

Authors:  Nisha I Sainani; Onofrio A Catalano; Nagaraj-Setty Holalkere; Andrew X Zhu; Peter F Hahn; Dushyant V Sahani
Journal:  Radiographics       Date:  2008 Sep-Oct       Impact factor: 5.333

8.  High-resolution computed tomography accurately predicts resectability in hilar cholangiocarcinoma.

Authors:  Thomas A Aloia; Chusilp Charnsangavej; Silvana Faria; Dario Ribero; Eddie K Abdalla; J Nicholas Vauthey; Steven A Curley
Journal:  Am J Surg       Date:  2007-06       Impact factor: 2.565

9.  Liver transplantation for hilar cholangiocarcinoma.

Authors:  Armin Thelen; Peter Neuhaus
Journal:  J Hepatobiliary Pancreat Surg       Date:  2007-09-28

10.  Asbestos bodies in a bile duct cancer after occupational exposure.

Authors:  M Szendröi; L Németh; G Vajta
Journal:  Environ Res       Date:  1983-04       Impact factor: 6.498

View more
  8 in total

1.  Immunohistochemically detected expression of Skp2, p27 kip1, and p-p27 (Thr187) in patients with cholangiocarcinoma.

Authors:  Jian Luo; Yi Zhou; Bing Wang; Qiang Li; Yongjun Chen; Hongzhen Lan
Journal:  Tumour Biol       Date:  2015-02-09

Review 2.  Magnetic resonance evaluations of biliary malignancy and condition at high-risk for biliary malignancy: Current status.

Authors:  Reiji Sugita
Journal:  World J Hepatol       Date:  2013-12-27

3.  Risk factors and classifications of hilar cholangiocarcinoma.

Authors:  Miguel Angel Suarez-Munoz; Jose Luis Fernandez-Aguilar; Belinda Sanchez-Perez; Jose Antonio Perez-Daga; Beatriz Garcia-Albiach; Ysabel Pulido-Roa; Naiara Marin-Camero; Julio Santoyo-Santoyo
Journal:  World J Gastrointest Oncol       Date:  2013-07-15

4.  The Prognostic Importance of the Number of Metastatic Lymph Nodes for Patients Undergoing Curative Resection Followed by Adjuvant Chemoradiotherapy for Extrahepatic Bile Duct Cancer.

Authors:  Byoung Hyuck Kim; Kyubo Kim; Eui Kyu Chie; Jeanny Kwon; Jin-Young Jang; Sun Whe Kim; Sae-Won Han; Do-Youn Oh; Seock-Ah Im; Tae-You Kim; Yung-Jue Bang; Sung W Ha
Journal:  J Gastrointest Surg       Date:  2015-08-04       Impact factor: 3.452

5.  CRM-1 knockdown inhibits extrahepatic cholangiocarcinoma tumor growth by blocking the nuclear export of p27Kip1.

Authors:  Jian Luo; Yongjun Chen; Qiang Li; Bing Wang; Yanqiong Zhou; Hongzhen Lan
Journal:  Int J Mol Med       Date:  2016-06-07       Impact factor: 4.101

6.  Molecular biomarkers in extrahepatic bile duct cancer patients undergoing chemoradiotherapy for gross residual disease after surgery.

Authors:  Hyeon Kang Koh; Hae Jin Park; Kyubo Kim; Eui Kyu Chie; Hye Sook Min; Sung W Ha
Journal:  Radiat Oncol J       Date:  2012-12-31

Review 7.  Research and Development of Atractylodes lancea (Thunb) DC. as a Promising Candidate for Cholangiocarcinoma Chemotherapeutics.

Authors:  Kesara Na-Bangchang; Tullayakorn Plengsuriyakarn; Juntra Karbwang
Journal:  Evid Based Complement Alternat Med       Date:  2017-11-14       Impact factor: 2.629

8.  Impact of radiation dose in postoperative radiotherapy after R1 resection for extrahepatic bile duct cancer: long term results from a single institution.

Authors:  Byoung Hyuck Kim; Eui Kyu Chie; Kyubo Kim; Jin-Young Jang; Sun Whe Kim; Do-Youn Oh; Yung-Jue Bang; Sung W Ha
Journal:  Oncotarget       Date:  2017-04-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.